Globus Medical has provided preliminary fourth-quarter 2025 financial results. The company forecasts a more robust bottom line in 2026 than what analysts anticipate.
AUDUBON, Pa., Jan. 07, 2026 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE: GMED), a leading musculoskeletal solutions company, today announced preliminary unaudited sales results for the fourth quart
Shares of Globus Medical, Inc. (NYSE: GMED - Get Free Report) have earned an average recommendation of "Moderate Buy" from the fourteen ratings firms that are covering the stock, Marketbeat Ratings re
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Here are some surging MedTech stocks - GMED, TMDX and HIMS - that may face slowing momentum in 2026.
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Fisher Asset Management LLC lessened its stake in Globus Medical, Inc. (NYSE: GMED) by 12.9% in the undefined quarter, according to its most recent disclosure with the Securities and Exchange Commissi
Globus Medical (GMED) could produce exceptional returns because of its solid growth attributes.
Investors with an interest in Medical - Instruments stocks have likely encountered both Globus Medical (GMED) and Penumbra (PEN). But which of these two stocks offers value investors a better bang for
American Century Companies Inc. boosted its holdings in shares of Globus Medical, Inc. (NYSE: GMED) by 123.5% during the undefined quarter, according to its most recent filing with the Securities and
December momentum picks gain traction as EXPE, ALL, DDS, KGC and GMED stand out after a mixed November.
Stocks like TTWO, GMED, ROK, CNQ and VICI stand out with strong sales growth expectations despite market uncertainty.
This medical products stock breaks out of a cup-with-handle base and is in a buy zone. The company makes technology used for spine surgery.
After reaching an important support level, Globus Medical, Inc. (GMED) could be a good stock pick from a technical perspective. GMED recently experienced a "golden cross" event, which saw its 50-day s
PARR, AU, GMED, ALNT and SNDK emerge as top picks after posting gains, rising estimates and sustained relative price outperformance.
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE